Currently, there are 456.96M common shares owned by the public and among those 456.08M shares have been available to trade.
The company’s stock has a 5-day price change of -26.17% and -28.11% over the past three months. GEHC shares are trading -24.85% year to date (YTD), with the 12-month market performance down to -33.59% lower. It has a 12-month low price of $58.04 and touched a high of $94.80 over the same period. GEHC has an average intraday trading volume of 3.55 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -24.50%, -30.21%, and -30.27% respectively.
Institutional ownership of GE HealthCare Technologies Inc (NASDAQ: GEHC) shares accounts for 85.71% of the company’s 456.96M shares outstanding.
It has a market capitalization of $26.87B and a beta (3y monthly) value of 1.56. The stock’s trailing 12-month PE ratio is 13.53, while the earnings-per-share (ttm) stands at $4.34. The company has a PEG of 1.45 and a Quick Ratio of 0.79 with the debt-to-equity ratio at 1.11. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.89% over the week and 3.61% over the month.
Earnings per share for the fiscal year are expected to increase by 4.81%, and 11.61% over the next financial year. EPS should grow at an annualized rate of 9.34% over the next five years, compared to 5.31% over the past 5-year period.
Looking at the support for the GEHC, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on March 11, 2025, with the firm’s price target at $85-$100. Jefferies coverage for the GE HealthCare Technologies Inc (GEHC) stock in a research note released on January 08, 2025 offered a Buy rating with a price target of $103. UBS was of a view on September 26, 2024 that the stock is Sell, while BTIG Research gave the stock Buy rating on September 18, 2024, issuing a price target of $100. JP Morgan on their part issued Neutral rating on September 09, 2024.
